Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate

The exponential rise in molecular and genomic data has generated a vast array of therapeutic targets. Oligonucleotide-based technologies to down regulate these molecular targets have promising therapeutic efficacy. However, there is relatively limited success in translating this into effective in vi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med
Main Authors: Satake, Noriko, Duong, Connie, Yoshida, Sakiko, Oestergaard, Michael, Chen, Cathy, Peralta, Rachael, Guo, Shuling, Seth, Punit P, Li, Yueju, Beckett, Laurel, Chung, Jong, Nolta, Jan, Nitin, Nitin, Tuscano, Joseph M
Formato: Artigo
Idioma:Inglês
Publicado em: Feinstein Institute for Medical Research 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5082301/
https://ncbi.nlm.nih.gov/pubmed/27455414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2015.00210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados